EKF Diagnostics (LON:EKF) Stock Price Passes Above 200-Day Moving Average – Should You Sell?

Shares of EKF Diagnostics Holdings plc (LON:EKF) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 25.29 and traded as high as GBX 27.90. EKF Diagnostics shares last traded at GBX 26.60, with a volume of 180,510 shares traded.

Analyst Ratings Changes

Separately, Stifel Nicolaus restated a “buy” rating and issued a GBX 35 target price on shares of EKF Diagnostics in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Buy rating, According to MarketBeat, the company has an average rating of “Buy” and an average target price of GBX 35.

EKF Diagnostics Price Performance

The stock has a 50 day simple moving average of GBX 25.02 and a two-hundred day simple moving average of GBX 25.29. The firm has a market cap of £114.53 million, a PE ratio of 56.60 and a beta of 0.53. The company has a debt-to-equity ratio of 2.01, a quick ratio of 1.77 and a current ratio of 4.16.

EKF Diagnostics (LON:EKF) last released its quarterly earnings data on Tuesday, March 24th. The company reported GBX 0.47 earnings per share for the quarter. EKF Diagnostics had a return on equity of 3.01% and a net margin of 4.12%. Sell-side analysts expect that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

? Point-of-Care analysers in the key areas of Hematology and Diabetes

? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.